tiprankstipranks
Trending News
More News >
Neurones (FR:NRO)
:NRO

Neurones (NRO) Price & Analysis

Compare
5 Followers

NRO Stock Chart & Stats


---

Financials

Options Prices

Currently, No data available
---

Ownership Overview

2.34%97.65%
Insiders
2.34%
Mutual Funds
― Other Institutional Investors
97.65% Public Companies and
Individual Investors

NRO FAQ

What was Neurones’s price range in the past 12 months?
Neurones lowest stock price was €39.45 and its highest was €52.00 in the past 12 months.
    What is Neurones’s market cap?
    Neurones’s market cap is €1.10B.
      When is Neurones’s upcoming earnings report date?
      Neurones’s upcoming earnings report date is Sep 10, 2025 which is in 112 days.
        How were Neurones’s earnings last quarter?
        Neurones released its earnings results on Mar 05, 2025. The company reported €1.156 earnings per share for the quarter, beating the consensus estimate of N/A by €1.156.
          Is Neurones overvalued?
          According to Wall Street analysts Neurones’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Neurones pay dividends?
            Neurones pays a Annually dividend of €1.2 which represents an annual dividend yield of 2.63%. See more information on Neurones dividends here
              What is Neurones’s EPS estimate?
              Neurones’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Neurones have?
              Neurones has 24,278,715 shares outstanding.
                What happened to Neurones’s price movement after its last earnings report?
                Neurones reported an EPS of €1.156 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.027%.
                  Which hedge fund is a major shareholder of Neurones?
                  Currently, no hedge funds are holding shares in FR:NRO
                  ---

                  Company Description

                  Neurones

                  Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, clouds, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of SAP integration and outsourcing; mobility, data, IoT, digital, agile, UX/UI, and DevOps; IT consulting for finance, big data, AI and blockchain; content management, business process management, paperless process; and IT training and working with change management. In addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, DevOps, CI/CD, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, UX/UI, and digital marketing, as well as internal process digitization, ECM/BPM, RPA, dematerialization, AI, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. The company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. Neurones S.A. was founded in 1984 and is headquartered in Nanterre, France.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Capgemini SE
                  Sopra Steria
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis